Genomma Lab Internacional, S.A.B. de C.V. (FRA:GEKA)

Genomma Lab Internacional Balance Sheet

Financials in millions MXN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,265	2,276	1,472	1,291	1,221	2,049
Cash & Short-Term Investments	2,265	2,276	1,472	1,291	1,221	2,049
Cash Growth	23.83%	54.60%	14.06%	5.71%	-40.41%	127.73%
Accounts Receivable	5,030	4,444	3,786	4,325	4,381	4,103
Other Receivables	2,389	2,195	2,453	2,439	2,819	3,008
Receivables	7,419	6,639	6,240	6,764	7,200	7,111
Inventory	2,098	2,176	1,911	2,397	2,095	1,939
Restricted Cash	-	14.07	16.24	7.32	43.93	55.09
Other Current Assets	745.86	961.45	997.7	853.1	961.53	883.83
Total Current Assets	12,821	12,067	10,637	11,312	11,521	12,037
Property, Plant & Equipment	3,726	3,559	3,415	3,593	3,366	2,852
Long-Term Investments	-	-	729.15	787.75	765	909.26
Goodwill	45.81	90.8	90.8	78.81	-	-
Other Intangible Assets	5,811	5,927	4,954	5,151	5,169	4,908
Long-Term Deferred Tax Assets	1,052	919.94	611.61	593.93	500.76	540.11
Long-Term Deferred Charges	-	212.55	209.04	-	-	-
Other Long-Term Assets	152.75	242.86	51.14	90.09	220.89	93.52
Total Assets	23,608	23,018	20,697	21,607	21,543	21,341
Accounts Payable	1,727	1,735	1,839	1,790	1,440	1,645
Accrued Expenses	28.84	2,347	1,880	1,731	1,895	1,854
Current Portion of Long-Term Debt	2,422	1,365	1,986	4,826	2,072	1,970
Current Portion of Leases	14.34	10.21	19.33	25.35	32.82	36.83
Current Income Taxes Payable	602.8	158.51	221.29	281.35	438.57	275.79
Other Current Liabilities	2,184	923.51	692.77	701.89	693	832.36
Total Current Liabilities	6,979	6,538	6,639	9,356	6,571	6,614
Long-Term Debt	4,920	5,065	4,206	1,552	3,832	4,454
Long-Term Leases	55.93	47.79	27.72	38.26	23.72	20.78
Pension & Post-Retirement Benefits	67.19	65.03	52.45	48.73	43	21.49
Long-Term Deferred Tax Liabilities	543.1	379.55	326.36	392.73	554.7	551.64
Other Long-Term Liabilities	37.35	37.35	62.04	66.35	446.15	836.79
Total Liabilities	12,603	12,133	11,314	11,454	11,471	12,498
Common Stock	1,825	1,825	1,862	1,913	1,913	1,913
Additional Paid-In Capital	39.75	39.75	39.75	39.75	39.75	39.75
Retained Earnings	12,222	11,512	10,767	10,372	9,419	8,085
Treasury Stock	-1,789	-1,741	-1,793	-1,701	-1,166	-1,143
Comprehensive Income & Other	-1,292	-751.13	-1,493	-471.11	-133.43	-51.47
Total Common Equity	11,006	10,885	9,383	10,153	10,072	8,842
Shareholders' Equity	11,006	10,885	9,383	10,153	10,072	8,842
Total Liabilities & Equity	23,608	23,018	20,697	21,607	21,543	21,341
Total Debt	7,413	6,488	6,239	6,441	5,961	6,482
Net Cash (Debt)	-5,148	-4,212	-4,767	-5,151	-4,740	-4,433
Net Cash Per Share	-5.14	-4.30	-4.98	-5.19	-4.70	-4.38
Filing Date Shares Outstanding	976.73	977.75	948.05	964.51	1,003	1,011
Total Common Shares Outstanding	976.73	977.75	948.05	964.51	1,003	1,011
Working Capital	5,842	5,528	3,997	1,956	4,950	5,424
Book Value Per Share	11.27	11.13	9.90	10.53	10.04	8.74
Tangible Book Value	5,149	4,868	4,338	4,923	4,903	3,934
Tangible Book Value Per Share	5.27	4.98	4.58	5.10	4.89	3.89
Land	-	245.65	245.62	239.5	265.15	265.14
Buildings	-	1,223	1,642	1,319	198.9	176.68
Machinery	-	2,973	1,558	1,295	1,002	774.2
Construction In Progress	-	113.76	827.74	1,511	2,514	2,143
Leasehold Improvements	-	204.56	105.83	116.71	108.24	86.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.